Material Agreements (Details) - USD ($) $ in Millions |
Nov. 17, 2021 |
Dec. 07, 2018 |
Dec. 19, 2017 |
Jun. 30, 2025 |
|---|---|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Upfront, non-refundable payment | $ 30.0 | |||
| Research and development and out-of-pocket | 50.00% | |||
| Cumulative milestone payments | $ 32.5 | |||
| Purchase price | $ 37.8 | |||
| Samsung Biologics Co., Ltd | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Purchase obligation, additional purchases, period | 4 years | |||
| Purchase obligation | $ 43.1 | |||
| Maximum | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Consideration paid | $ 20.0 | |||
| Maximum | Upon Achievement Of Development Regulatory And Sales Milestones | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Contingent milestone payments | $ 420.0 |